Peter Kolchinsky, Director: ARS Pharmaceuticals SPRY Buy · Filed 23/09/25

Trade details

Type: Insider buy
Amount: $7,450,812.27
Shares · price: 2,508,691 sh · $2.97 a share
Held after: 8,365,465 sh
Stock: ARS Pharmaceuticals SPRY
Person: Peter KolchinskyDirector
Trade date: 23/09/21
Filed: 23/09/25
Days to filing: 4 days

6 insiders bought this week

Insiders buying this week: 6 insiders
Holding change: +42.8%

ARS Pharmaceuticals trades, last 26 weeks

What else happened in ARS Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/08/22~23/10/21

Peter Kolchinsky's recent trades

Peter KolchinskyDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$275.3K
31,000 sh
$275.3K
Filed 06/29
Traded 06/25
Peter KolchinskyDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
Peter Kolchinsky10% Owner
SellWerewolf Therapeutics
Sell
Werewolf Therapeutics
HOWL
$136.2K
389,216 sh
$136.2K
Filed 06/22
Traded 06/17
Peter Kolchinsky10% Owner
SellWerewolf Therapeutics
Sell
Werewolf Therapeutics
HOWL
$9,693
27,695 sh
$9,693
Filed 06/22
Traded 06/17
Peter Kolchinsky10% Owner
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.5M
61,523 sh
$1.5M
Filed 06/17
Traded 06/16

Peter Kolchinsky, Director — bought $7.5M of ARS Pharmaceuticals SPRY · 2,508,691 sh @ $2.97 | Whalegun